Taysha Gene Therapies
Taysha Gene Therapies is a company focused on gene therapy programs for central nervous system diseases.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Taysha Gene Therapies aims to eradicate monogenic CNS disease and focuses on gene therapy programs with the potential to transform care for patients with central nervous system diseases, starting with Rett syndrome.
History
Taysha Gene Therapies states that it wants to do more than just treat monogenic CNS disease; it wants to eradicate it. Its science focuses on gene therapy programs with the potential to transform care for patients with central nervous system (CNS) diseases, starting with Rett syndrome.
Recent events
Taysha Gene Therapies reports full-year 2020 results[5]
Reported:
Taysha Gene Therapies reported financial results for the full year ended December 31, 2020, including a net loss of $60.0 million.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/taysha-gene-therapies · Editorial policy · How profiles are compiled